Piper Sandler Upgrades MetLife to Overweight, Raises Price Target to $110
Piper Sandler analyst Paul Newsome upgrades MetLife (NYSE:MET) from Neutral to Overweight and raises the price target from $99 to $110.
Share
Why It Matters
A major analyst thinks MetLife stock looks like a good buy. They raised their price target to $110 from $99, saying the company looks stronger.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.